vs

Side-by-side financial comparison of Climb Global Solutions, Inc. (CLMB) and MANNKIND CORP (MNKD). Click either name above to swap in a different company.

Climb Global Solutions, Inc. is the larger business by last-quarter revenue ($182.4M vs $112.0M, roughly 1.6× MANNKIND CORP). Climb Global Solutions, Inc. runs the higher net margin — 1.8% vs -14.2%, a 16.1% gap on every dollar of revenue. On growth, MANNKIND CORP posted the faster year-over-year revenue change (45.8% vs 32.1%). Over the past eight quarters, Climb Global Solutions, Inc.'s revenue compounded faster (40.7% CAGR vs 30.0%).

Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.

CLMB vs MNKD — Head-to-Head

Bigger by revenue
CLMB
CLMB
1.6× larger
CLMB
$182.4M
$112.0M
MNKD
Growing faster (revenue YoY)
MNKD
MNKD
+13.7% gap
MNKD
45.8%
32.1%
CLMB
Higher net margin
CLMB
CLMB
16.1% more per $
CLMB
1.8%
-14.2%
MNKD
Faster 2-yr revenue CAGR
CLMB
CLMB
Annualised
CLMB
40.7%
30.0%
MNKD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLMB
CLMB
MNKD
MNKD
Revenue
$182.4M
$112.0M
Net Profit
$3.3M
$-15.9M
Gross Margin
14.5%
87.6%
Operating Margin
2.1%
-6.9%
Net Margin
1.8%
-14.2%
Revenue YoY
32.1%
45.8%
Net Profit YoY
-9.5%
-314.9%
EPS (diluted)
$0.18
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLMB
CLMB
MNKD
MNKD
Q1 26
$182.4M
Q4 25
$193.8M
$112.0M
Q3 25
$161.3M
$82.1M
Q2 25
$159.3M
$76.5M
Q1 25
$138.0M
$78.4M
Q4 24
$161.8M
$76.8M
Q3 24
$119.3M
$70.1M
Q2 24
$92.1M
$72.4M
Net Profit
CLMB
CLMB
MNKD
MNKD
Q1 26
$3.3M
Q4 25
$7.0M
$-15.9M
Q3 25
$4.7M
$8.0M
Q2 25
$6.0M
$668.0K
Q1 25
$3.7M
$13.2M
Q4 24
$7.0M
$7.4M
Q3 24
$5.5M
$11.6M
Q2 24
$3.4M
$-2.0M
Gross Margin
CLMB
CLMB
MNKD
MNKD
Q1 26
14.5%
Q4 25
15.4%
87.6%
Q3 25
15.9%
94.5%
Q2 25
16.5%
94.0%
Q1 25
16.9%
95.2%
Q4 24
19.3%
93.7%
Q3 24
20.3%
95.4%
Q2 24
20.2%
92.3%
Operating Margin
CLMB
CLMB
MNKD
MNKD
Q1 26
2.1%
Q4 25
4.9%
-6.9%
Q3 25
4.3%
23.0%
Q2 25
5.0%
6.9%
Q1 25
3.5%
28.5%
Q4 24
7.2%
34.5%
Q3 24
7.1%
18.2%
Q2 24
4.6%
22.9%
Net Margin
CLMB
CLMB
MNKD
MNKD
Q1 26
1.8%
Q4 25
3.6%
-14.2%
Q3 25
2.9%
9.7%
Q2 25
3.7%
0.9%
Q1 25
2.7%
16.8%
Q4 24
4.3%
9.7%
Q3 24
4.6%
16.5%
Q2 24
3.7%
-2.8%
EPS (diluted)
CLMB
CLMB
MNKD
MNKD
Q1 26
$0.18
Q4 25
$1.51
$-0.05
Q3 25
$1.02
$0.03
Q2 25
$1.30
$0.00
Q1 25
$0.81
$0.04
Q4 24
$1.52
$0.03
Q3 24
$1.19
$0.04
Q2 24
$0.75
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLMB
CLMB
MNKD
MNKD
Cash + ST InvestmentsLiquidity on hand
$41.8M
$171.3M
Total DebtLower is stronger
$354.6M
Stockholders' EquityBook value
$118.4M
$-51.0M
Total Assets
$458.8M
$792.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLMB
CLMB
MNKD
MNKD
Q1 26
$41.8M
Q4 25
$36.6M
$171.3M
Q3 25
$49.8M
$260.0M
Q2 25
$28.6M
$179.0M
Q1 25
$32.5M
$181.5M
Q4 24
$29.8M
$197.3M
Q3 24
$22.1M
$251.6M
Q2 24
$48.4M
$247.8M
Total Debt
CLMB
CLMB
MNKD
MNKD
Q1 26
Q4 25
$354.6M
Q3 25
$109.7M
Q2 25
$36.2M
Q1 25
$36.1M
Q4 24
$36.1M
Q3 24
$227.9M
Q2 24
$227.6M
Stockholders' Equity
CLMB
CLMB
MNKD
MNKD
Q1 26
$118.4M
Q4 25
$116.6M
$-51.0M
Q3 25
$109.3M
$-44.6M
Q2 25
$105.2M
$-55.0M
Q1 25
$95.6M
$-58.6M
Q4 24
$90.6M
$-78.8M
Q3 24
$87.7M
$-209.9M
Q2 24
$79.8M
$-225.8M
Total Assets
CLMB
CLMB
MNKD
MNKD
Q1 26
$458.8M
Q4 25
$460.2M
$792.2M
Q3 25
$376.1M
$494.6M
Q2 25
$420.7M
$411.7M
Q1 25
$370.1M
$410.1M
Q4 24
$469.2M
$393.8M
Q3 24
$371.9M
$464.2M
Q2 24
$302.8M
$443.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLMB
CLMB
MNKD
MNKD
Operating Cash FlowLast quarter
$-8.0M
Free Cash FlowOCF − Capex
$-10.0M
FCF MarginFCF / Revenue
-8.9%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLMB
CLMB
MNKD
MNKD
Q1 26
Q4 25
$-11.9M
$-8.0M
Q3 25
$22.2M
$23.6M
Q2 25
$-2.2M
$8.9M
Q1 25
$8.5M
$-6.4M
Q4 24
$16.0M
$22.6M
Q3 24
$-3.6M
$9.3M
Q2 24
$7.3M
$3.8M
Free Cash Flow
CLMB
CLMB
MNKD
MNKD
Q1 26
Q4 25
$-10.0M
Q3 25
$22.5M
Q2 25
$7.8M
Q1 25
$-6.7M
Q4 24
$19.7M
Q3 24
$7.9M
Q2 24
$861.0K
FCF Margin
CLMB
CLMB
MNKD
MNKD
Q1 26
Q4 25
-8.9%
Q3 25
27.4%
Q2 25
10.2%
Q1 25
-8.6%
Q4 24
25.7%
Q3 24
11.3%
Q2 24
1.2%
Capex Intensity
CLMB
CLMB
MNKD
MNKD
Q1 26
Q4 25
1.8%
Q3 25
1.4%
Q2 25
1.5%
Q1 25
0.4%
Q4 24
3.8%
Q3 24
2.0%
Q2 24
4.1%
Cash Conversion
CLMB
CLMB
MNKD
MNKD
Q1 26
Q4 25
-1.70×
Q3 25
4.73×
2.96×
Q2 25
-0.37×
13.40×
Q1 25
2.30×
-0.48×
Q4 24
2.29×
3.05×
Q3 24
-0.66×
0.81×
Q2 24
2.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLMB
CLMB

Segment breakdown not available.

MNKD
MNKD

Products$50.4M45%
Royalty$33.6M30%
Afrezza$22.9M20%
V Go$4.3M4%

Related Comparisons